We wanted to bring your attention to an opportunity provided by Gilead UK & Ireland HIV Fellowship and Medical Grants Programme, which is now accepting applications. The Programme is a medical grants funding stream with the ultimate aim to end the HIV epidemic for everyone, everywhere, and enable people to live their best lives.
This year, they are inviting applications from healthcare and third sector organisations, including pharmacists working in HIV care, for initiatives and projects which support the UK & Ireland’s ambition of “Getting to Zero”:
- Zero new HIV transmissions
- Zero difference in HIV-related stigma, health outcomes and quality of life for people living with HIV
- Zero persons lost to care
If you have a project that falls outside of this scope, but which will add clinical value or which investigates an area of unmet need within the field of HIV, you may still apply. All applications will be appraised based on their individual merit and focus on driving positive change in patient care.
The Programme for HIV has a total funding amount of £500,000 available for successful projects in 2023.
The application window will close on Friday 30th June 2023.
If you have a project which you think may be relevant, we encourage you to learn if your project is eligible and apply on the Gilead UK and Ireland website. In addition, information on our upcoming live Q&A virtual support clinic taking place Thursday 1st June, 12:30 – 1:30pm BST can be found on the website. We encourage you to register if you have any questions for Gilead HIV representatives about your potential project or the application process.
Should you have any general enquiries or questions regarding the process, application form, or your project eligibility, please email gileadfellowship@axon-com.com who will be happy to support you with your request.
Please note that any applications which generate specific patient clinical outcomes (either classified as interventional or non-interventional studies according to EUDRACT criteria) cannot be accepted. These fall under the category of a clinical trial and, as such, will be considered out of scope of the Fellowship Programme.